Levo-alpha-acetylmethadol (LAAM), also known as levomethadyl acetate, was recently
approved by the Food and Drug Administration for the management of opiate dependence …

levo-α-Acetylmethadol (LAAM) and methadone are full μ-opioid agonists used to treat opioid
dependence. Current labeling indicates that LAAM is less potent than methadone. Clinical …

Levomethadyl Acetate (LAAM) for the Treatment of Opioid Dependence: A Multisite, Open-Label
Study of LAAM Safety and an Evaluati Page 1 Levomethadyl Acetate (LAAM) for the …

Abstract Levo-alpha-acetylmethadol (LAAM) pharmacotherapy was offered to twelve
patients who continued illicit opioid abuse after> eleven months in methadone maintenance …

Levo-alpha-acetylmethadol (LAAM) is under investigation for maintenance therapy of
persons addicted to opiate drugs. Jaffe et al.(5, 6, 7) reported that LAAM was successful as a …

Abstract l-α-Acetylmethadol (LAAM) was recently approved as a substitute for methadone.
LAAM, methadone, and their common metabolite, methadol, are extensively N …

ABSTRACT l-α-Acetylmethadol (LAAM) is an alternative to methadone for the maintenance
treatment of opioid dependence. LAAM has a longer therapeutic half-life than methadone …

Methadone is currently the most widely used agent to manage opioid dependence, but
clinical experience has highlighted some limitations with its use. In particular, a relatively …

LAAM) is a synthetic congener [1, 21 of methadone. The presence of two asymmetric carbon
atoms in the molecule gives rise to two diastereoisomeric pairs [3] a and 0, of which the a …

Objective.—To compare the clinical efficacy of different doses of levomethadyl acetate
hydrochloride (known as LAAM) in the treatment of opioid dependence. Design.—A …